SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-037574
Filing Date
2017-07-20
Accepted
2017-07-20 20:52:25
Documents
1
Period of Report
2017-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 v471199_4.html 4  
1 FORM 4 v471199_4.xml 4 4184
  Complete submission text file 0001144204-17-037574.txt   5755
Mailing Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016 646-440-9310
IMMUNE PHARMACEUTICALS INC (Issuer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNE PHARMACEUTICALS INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Maza Elliot M (Reporting) CIK: 0001270365 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36602 | Film No.: 17975373